Novavax is looking ahead to 2024, with the TGA currently assessing its submission for its updated monovalent XBB.1.5 COVID-19 vaccine and a plan to progress the development of its combination COVID-influenza vaccine. …
Novavax looking to 2024 with monovalent COVID vaccine and potential combination
December 20, 2023 Latest NewsBioPharmaNews of the DayBioPharmaDispatch Executive
Latest Video
New Stories
-
The private market might do what two decades of PBS reform attempts couldn't
October 12, 2026 - - Latest News -
The full set of numbers tell the story and reveal the massive funding shortfall
October 12, 2026 - - Latest News -
Private prescription market heads towards $4 billion as PBS spending stalls
October 12, 2026 - - Latest News -
The 'Dispatched' Podcast Week in Review - Series 5. Ep.35
October 9, 2026 - - Podcast -
PhRMA goes to court over price rule that uses Australia as a benchmark
October 9, 2026 - - Latest News -
A tale of two systems with billions shifting to the private market
October 9, 2026 - - Latest News -
GLP-1s are quickly reshaping the Australian prescription medicines market
October 9, 2026 - - Latest News